The U.S. Food and Drug Administration (FDA) has approved the first drug to treat peanut allergy in children. The remedy, Palforzia, mitigates allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. According to an FDA news release, treatment with Palforzia may begin in individuals ages 4 through 17 years with a confirmed… Continue reading Peanut Allergy: A New Medication for Children
Tag: new treatment
New Migraine Treatment Approved for Adults
The U.S. Food and Drug Administration (FDA) has approved Ubrelvy (ubrogepant) tablets for immediate treatment of migraine with or without aura in adults. Ubrelvy is not indicated for the preventive treatment of migraine. It is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved for the acute treatment of migraine.… Continue reading New Migraine Treatment Approved for Adults
New Treatment for MS Approved
A new treatment has been approved to treat relapsing forms of multiple sclerosis (MS) in adults. The oral treatment, Mavenclad, is approved for treating relapsing-remitting forms of the illness as well as active secondary progressive disease. The federal Food and Drug Administration (FDA), which approved Mavenclad, said that it is not recommended for MS patients… Continue reading New Treatment for MS Approved
New Psoriasis Drug Is More Effective Than Current Treatment
A phase II clinical trial led by Northwestern Medicine investigators shows that a new psoriasis drug called guselkumab has greater efficacy than the current standard of care for the chronic skin condition. In the study, published in July 2015 in the New England Journal of Medicine, investigators compared guselkumab to adalimumab, the most common medication… Continue reading New Psoriasis Drug Is More Effective Than Current Treatment